Trial intelligence / Profile preview

HKIIM-KU Formula for Gout

NCT05499312Phase 2Completed

Sponsor
The Chinese University of Hong Kong
Start
Oct 2022
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HKIIM-KU formula in gout, sponsored by The Chinese University of Hong Kong. Started Oct 2022; status: completed.

02

Drugs

HKIIM-KU formula
03

Conditions

gout

Beyond the preview

Go deeper on NCT05499312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05499312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call